Tarsus Pharmaceuticals Inc (TARS)
Operating Cash Flow (Statement)
$66.77M
Quarterly · Period ending: · USD
TARS Operating Cash Flow (Statement)
Latest reported$66.77Mperiod ending
Latest reported$66.77Mperiod ending
TARS Quarterly Cash from Operations (-$295.75K → $66.77M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
TARS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 66,767,000 | |
| -24,652,000 | |
| 19,330,000 | |
| 18,257,000 | |
| -29,387,000 | |
| -20,651,000 | |
| -22,182,000 | |
| -8,652,000 | |
| -14,404,000 | |
| -37,789,000 | |
| -39,335,000 | |
| -32,362,000 | |
| -23,826,000 | |
| -21,970,000 | |
| -10,874,000 | |
| -18,611,000 | |
| -4,259,000 | |
| -15,286,000 | |
| -12,121,000 | |
| 7,112,000 | |
| 20,551,000 | |
| -11,794,000 | |
| -10,013,000 | |
| -6,572,000 | |
| -2,557,000 | |
| -1,996,000 | |
| -806,000 | |
| -570,000 | |
| -295,750 | |
| -295,750 |